Arecor Therapeutics PLC (AREC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.178x

Based on the latest financial reports, Arecor Therapeutics PLC (AREC) has a cash flow conversion efficiency ratio of -0.178x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.15 Million ≈ $-139.56 USD) by net assets (GBX6.45 Million ≈ $785.27 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Arecor Therapeutics PLC to measure how many days the company can operate on defensive assets alone.

Arecor Therapeutics PLC - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Arecor Therapeutics PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Arecor Therapeutics PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Arecor Therapeutics PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sino-German United AG F:SGU	N/A
Global PVQ SE HM:QCE	3.126x
Checkit PLC LSE:CKT	-0.132x
Multistack International Ltd AU:MSI	-0.834x
Elixxer Ltd V:ELXR	0.024x
Altair Resources Inc V:AVX	0.002x
Shuttle Pharmaceuticals Inc NASDAQ:SHPH	-0.722x
Annum Bhd KLSE:5082	0.001x

Annual Cash Flow Conversion Efficiency for Arecor Therapeutics PLC (2018–2025)

The table below shows the annual cash flow conversion efficiency of Arecor Therapeutics PLC from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Arecor Therapeutics PLC (AREC) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX6.45 Million ≈ $785.27	GBX-2.29 Million ≈ $-278.63	-0.355x	+79.27%
2024-12-31	GBX5.35 Million ≈ $650.82	GBX-9.15 Million ≈ $-1.11K	-1.712x	-179.16%
2023-12-31	GBX9.53 Million ≈ $1.16K	GBX-5.84 Million ≈ $-710.68	-0.613x	+0.73%
2022-12-31	GBX17.45 Million ≈ $2.12K	GBX-10.78 Million ≈ $-1.31K	-0.618x	-110.20%
2021-12-31	GBX18.55 Million ≈ $2.26K	GBX-5.45 Million ≈ $-663.11	-0.294x	+87.75%
2020-12-31	GBX773.79K ≈ $94.15	GBX-1.86 Million ≈ $-225.90	-2.399x	-1577.65%
2019-12-31	GBX3.21 Million ≈ $390.31	GBX-458.80K ≈ $-55.82	-0.143x	+75.93%
2019-05-31	GBX4.22 Million ≈ $512.95	GBX-2.50 Million ≈ $-304.76	-0.594x	+19.14%
2018-05-31	GBX670.33K ≈ $81.56	GBX-492.57K ≈ $-59.93	-0.735x	--

About Arecor Therapeutics PLC

LSE:AREC UK Biotechnology

Market Cap

$287.12K

GBX2.36 Billion GBX

Market Cap Rank

#31017 Global

#984 in UK

Share Price

GBX62.50

Change (1 day)

+0.00%

52-Week Range

GBX43.50 - GBX92.50

All Time High

GBX450.00